Top

Published in:

Open Access 01-08-2019 | Primary Immunodeficiency | Original Article

Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review

Authors: Hemmo A. F. Yska, Kim Elsink, Taco W. Kuijpers, Geert W. J. Frederix, Mariëlle E. van Gijn, Joris M. van Montfrans

Published in: Journal of Clinical Immunology | Issue 6/2019

Abstract

Background

As the application of next generation sequencing (NGS) is moving to earlier stages in the diagnostic pipeline for primary immunodeficiencies (PIDs), re-evaluation of its effectiveness is required. The aim of this study is to systematically review the diagnostic yield of NGS in PIDs.

Methods

PubMed and Embase databases were searched for relevant studies. Studies were eligible when describing the use of NGS in patients that had previously been diagnosed with PID on clinical and/or laboratory findings. Relevant data on study characteristics, technological performance and diagnostic yield were extracted.

Results

Fourteen studies were eligible for data extraction. Six studies described patient populations from specific PID subcategories. The remaining studies included patients with unsorted PIDs. The studies were based on populations from Italy, Iran, Turkey, Thailand, the Netherlands, Norway, Saudi Arabia, Sweden, the UK, and the USA. Eight studies used an array-based targeted gene panel, four used WES in combination with a PID filter, and two used both techniques. The mean reported reading depth ranged from 98 to 1337 times. Five studies described the sensitivity of the applied techniques, ranging from 83 to 100%, whereas specificity ranged from 45 to 99.9%. The percentage of patients who were genetically diagnosed ranged from 15 to 79%. Several studies described clinical implications of the genetic findings.

Discussion

NGS has the ability to contribute significantly to the identification of molecular mechanisms in PID patients. The diagnostic yield highly depends on population and on the technical circumstances under which NGS is employed. Further research is needed to determine the exact diagnostic yield and clinical implications of NGS in patients with PID.

Available only for authorised users

van der Spek J, Groenwold RHH, van der Burg M, van Montfrans JM. TREC based newborn screening for severe combined immunodeficiency disease: a systematic review. J Clin Immunol. 2015;35:416–30. https://doi.org/10.1007/s10875-015-0152-6.CrossRefPubMedPubMedCentral

Gray PEA, Namasivayam M, Ziegler JB. Recurrent infection in children: when and how to investigate for primary immunodeficiency? J Paediatr Child Health. 2012;48:202–9. https://doi.org/10.1111/j.1440-1754.2011.02080.x.CrossRefPubMed

Shillitoe B, Bangs C, Guzman D, Gennery AR, Longhurst HJ, Slatter M, et al. The United Kingdom primary immune deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. 2018;192:284–91. https://doi.org/10.1111/cei.13125.CrossRefPubMedPubMedCentral

Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Tan Y, et al. Use of genetic testing for primary immunodeficiency patients. J Clin Immunol. 2018;38:320–9. https://doi.org/10.1007/s10875-018-0489-8.CrossRefPubMed

Gallo V, Dotta L, Giardino G, Cirillo E, Lougaris V, D’Assante R, et al. Diagnostics of primary immunodeficiencies through next-generation sequencing. Front Immunol. 2016;7. https://doi.org/10.3389/fimmu.2016.00466.

Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol. 2010;7. https://doi.org/10.3389/fimmu.2016.00466.

Alkan G, Keles S, Reisli İ. Evaluation of clinical and immunological characteristics of children with common variable immunodeficiency. Int J Pediatr. 2018;2018:1–8. https://doi.org/10.1155/2018/3527480.CrossRef

Stoddard JL, Niemela JE, Fleisher TA, Rosenzweig SD. Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front Immunol. 2014;5. https://doi.org/10.3389/fimmu.2014.00531.

Seleman M, Hoyos-Bachiloglu R, Geha RS, Chou J. Uses of next-generation sequencing technologies for the diagnosis of primary Immunodeficiencies. Front Immunol. 2017;8. https://doi.org/10.3389/fimmu.2017.00847.

10.

Notarangelo LD, Sorensen R. Is it necessary to identify molecular defects in primary immunodeficiency disease? J Allergy Clin Immunol. 2008;122:1069–73. https://doi.org/10.1016/j.jaci.2008.08.038.CrossRefPubMed

11.

Raje N, Soden S, Swanson D, Ciaccio CE, Kingsmore SF, Dinwiddie DL. Utility of next generation sequencing in clinical primary immunodeficiencies. Curr Allergy Asthma Rep. 2014;14:468. https://doi.org/10.1007/s11882-014-0468-y.CrossRefPubMedPubMedCentral

12.

Bisgin A, Boga I, Yilmaz M, Bingol G, Altintas D. The utility of next-generation sequencing for primary immunodeficiency disorders: experience from a clinical diagnostic laboratory. Biomed Res Int. 2018;2018:1–5. https://doi.org/10.1155/2018/9647253.CrossRef

13.

Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128.CrossRefPubMed

14.

Picard C, Fischer A. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur J Immunol. 2014;44:2854–61. https://doi.org/10.1002/eji.201444669.CrossRefPubMed

15.

Engelhardt KR, Xu Y, Grainger A, Germani Batacchi MGC, Swan DJ, Willet JDP, et al. Identification of heterozygous single- and multi-exon deletions in IL7R by whole exome sequencing. J Clin Immunol. 2017;37:42–50. https://doi.org/10.1007/s10875-016-0343-9.CrossRefPubMed

16.

van Schouwenburg PA, Davenport EE, Kienzler A-K, Marwah I, Wright B, Lucas M, et al. Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol. 2015;160:301–14. https://doi.org/10.1016/j.clim.2015.05.020.CrossRefPubMedPubMedCentral

17.

Rae W, Ward D, Mattocks C, Pengelly RJ, Eren E, Patel SV, et al. Clinical efficacy of a next-generation sequencing gene panel for primary immunodeficiency diagnostics. Clin Genet. 2018;93:647–55. https://doi.org/10.1111/cge.13163.CrossRefPubMed

18.

Fang M, Abolhassani H, Lim CK, Zhang J, Hammarström L. Next generation sequencing data analysis in primary immunodeficiency disorders - future directions. J Clin Immunol. 2016;36:68–75. https://doi.org/10.1007/s10875-016-0260-y.CrossRefPubMed

19.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. standards for reporting of diagnostic accuracy. Clin Chem. 2003 Jan;49(1):1–6. Available from http://www.ncbi.nlm.nih.gov/pubmed/12507953.

20.

Yu H, Zhang VW, Stray-Pedersen A, Hanson IC, Forbes LR, de la Morena MT, et al. Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing. J Allergy Clin Immunol. 2016;138:1142–1151.e2. https://doi.org/10.1016/j.jaci.2016.05.035.CrossRefPubMed

21.

Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova J-L, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7. https://doi.org/10.3389/fimmu.2016.00220.

22.

Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med [Internet. 2019;21(1):243–51 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29921932.

23.

Nijman IJ, van Montfrans JM, Hoogstraat M, Boes ML, van de Corput L, Renner ED, et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol. 2014;133:529–534.e1. https://doi.org/10.1016/j.jaci.2013.08.032.CrossRefPubMed

24.

Al-Mousa H, Abouelhoda M, Monies DM, Al-Tassan N, Al-Ghonaium A, Al-Saud B, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol. 2016;137:1780–7. https://doi.org/10.1016/j.jaci.2015.12.1310.CrossRefPubMed

25.

Mukda E, Trachoo O, Pasomsub E, Tiyasirichokchai R, Iemwimangsa N, Sosothikul D, et al. Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis. Int J Hematol. 2017;106:282–90. https://doi.org/10.1007/s12185-017-2223-3.CrossRefPubMed

26.

Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139:232–45. https://doi.org/10.1016/j.jaci.2016.05.042.CrossRefPubMed

27.

Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141:1450–8. https://doi.org/10.1016/j.jaci.2017.06.049.CrossRefPubMed

28.

Al-Herz W, Aldhekri H, Barbouche M-R, Rezaei N. Consanguinity and primary immunodeficiencies. Hum Hered. 2014;77:138–43. https://doi.org/10.1159/000357710.CrossRefPubMed

29.

Mousallem T, Urban TJ, McSweeney KM, Kleinstein SE, Zhu M, Adeli M, et al. Clinical application of whole-genome sequencing in patients with primary immunodeficiency. J Allergy Clin Immunol. 2015;136:476–479.e6. https://doi.org/10.1016/j.jaci.2015.02.040.CrossRefPubMedPubMedCentral

30.

Kienzler A-K, Hargreaves CE, Patel SY. The role of genomics in common variable immunodeficiency disorders. Clin Exp Immunol. 2017;188:326–32. https://doi.org/10.1111/cei.12947.CrossRefPubMed

31.

Ameratunga R, Lehnert K, Woon S-T, Gillis D, Bryant VL, Slade CA, et al. Review: diagnosing common variable immunodeficiency disorder in the era of genome sequencing. Clin Rev Allergy Immunol. 2018;54:261–8. https://doi.org/10.1007/s12016-017-8645-0.CrossRefPubMed

32.

Moens LN, Falk-Sörqvist E, Asplund AC, Bernatowska E, Smith CIE, Nilsson M. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS One. 2014;9:e114901. https://doi.org/10.1371/journal.pone.0114901.CrossRefPubMedPubMedCentral

33.

Erman B, Bilic I, Hirschmugl T, Salzer E, Boztug H, Sanal Ö, et al. Investigation of genetic defects in severe combined immunodeficiency patients from Turkey by targeted sequencing. Scand J Immunol. 2017;85:227–34. https://doi.org/10.1111/sji.12523.CrossRefPubMed

34.

Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol. 2016;138:957–69. https://doi.org/10.1016/j.jaci.2016.08.003.CrossRefPubMedPubMedCentral

35.

Whitford W, Lehnert K, Snell RG, Jacobsen JC. Evaluation of the performance of copy number variant prediction tools for the detection of deletions from whole genome sequencing data. J Biomed Inform [Internet. 2019;94:103174. https://doi.org/10.1016/j.jbi.2019.103174.CrossRefPubMed

36.

Suzuki T, Sasahara Y, Kikuchi A, Kakuta H, Kashiwabara T, Ishige T, et al. Targeted sequencing and immunological analysis reveal the involvement of primary immunodeficiency genes in pediatric IBD: a Japanese multicenter study. J Clin Immunol. 2017;37:67–79. https://doi.org/10.1007/s10875-016-0339-5.CrossRefPubMed

Title: Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review
Authors: Hemmo A. F. Yska
Kim Elsink
Taco W. Kuijpers
Geert W. J. Frederix
Mariëlle E. van Gijn
Joris M. van Montfrans
Publication date: 01-08-2019
Publisher: Springer US
Keyword: Primary Immunodeficiency
Published in: Journal of Clinical Immunology / Issue 6/2019
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-019-00656-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review

Abstract

Background

Methods

Results

Discussion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 6/2019

Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2

Compound Heterozygous DOCK8 Mutations in a Patient with B Lymphoblastic Leukemia and EBV-Associated Diffuse Large B Cell Lymphoma

Myriad Faces of Chronic Granulomatous Disease: All in an Indian Family with Novel CYBB Defect

Prof. Dr. Beatriz Tavares Costa-Carvalho Obituary

Respiratory Complications in Patients with Hyper IgM Syndrome

Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page